SG11201706739WA - Novel pharmaceutical uses - Google Patents
Novel pharmaceutical usesInfo
- Publication number
- SG11201706739WA SG11201706739WA SG11201706739WA SG11201706739WA SG11201706739WA SG 11201706739W A SG11201706739W A SG 11201706739WA SG 11201706739W A SG11201706739W A SG 11201706739WA SG 11201706739W A SG11201706739W A SG 11201706739WA SG 11201706739W A SG11201706739W A SG 11201706739WA
- Authority
- SG
- Singapore
- Prior art keywords
- novel pharmaceutical
- pharmaceutical uses
- novel
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1505526.2A GB201505526D0 (en) | 2015-03-31 | 2015-03-31 | Novel pharmaceutical uses |
| GBGB1521015.6A GB201521015D0 (en) | 2015-11-27 | 2015-11-27 | Novel pharmaceutical uses |
| PCT/JP2016/061185 WO2016159386A1 (en) | 2015-03-31 | 2016-03-30 | Novel pharmaceutical uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201706739WA true SG11201706739WA (en) | 2017-09-28 |
Family
ID=55806738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201706739WA SG11201706739WA (en) | 2015-03-31 | 2016-03-30 | Novel pharmaceutical uses |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20180085361A1 (en) |
| EP (1) | EP3277279A1 (en) |
| JP (1) | JP2018513140A (en) |
| KR (1) | KR20170132260A (en) |
| CN (1) | CN107530335A (en) |
| AU (1) | AU2016241069A1 (en) |
| BR (1) | BR112017021024A2 (en) |
| CA (1) | CA2981244A1 (en) |
| CL (1) | CL2017002325A1 (en) |
| CO (1) | CO2017010019A2 (en) |
| CR (1) | CR20170404A (en) |
| DO (1) | DOP2017000218A (en) |
| EA (1) | EA201792148A1 (en) |
| EC (1) | ECSP17072984A (en) |
| IL (1) | IL254419A0 (en) |
| MA (1) | MA41850A (en) |
| MX (1) | MX2017012414A (en) |
| PE (1) | PE20180195A1 (en) |
| PH (1) | PH12017501751A1 (en) |
| SG (1) | SG11201706739WA (en) |
| TN (1) | TN2017000416A1 (en) |
| WO (1) | WO2016159386A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2980109A1 (en) | 2015-03-31 | 2016-10-06 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
| WO2019013310A1 (en) | 2017-07-10 | 2019-01-17 | Takeda Pharmaceutical Company Limited | Preparation comprising vonoprazan |
| WO2024027549A1 (en) * | 2022-08-04 | 2024-02-08 | 江苏柯菲平医药股份有限公司 | Pharmaceutical composition containing pyrrole gastric acid secretion inhibitor and preparation method therefor |
| CN116270443A (en) * | 2022-10-27 | 2023-06-23 | 广州白云山天心制药股份有限公司 | Fu Nuola raw fumaric acid injection and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7662832B2 (en) | 2004-09-03 | 2010-02-16 | Yuhan Corporation | Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| US20080255200A1 (en) * | 2007-04-11 | 2008-10-16 | Auspex Pharmaceuticals, Inc. | Substituted benzimidazoles |
| BRPI0916689A2 (en) | 2008-07-28 | 2015-11-17 | Takeda Pharmaceutical | stabilized pharmaceutical composition, solid preparation, and methods for stabilizing a pharmaceutical composition, and for stabilizing a solid preparation. |
| WO2011004882A1 (en) | 2009-07-09 | 2011-01-13 | ラクオリア創薬株式会社 | Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
| CA2902624C (en) | 2013-02-28 | 2021-05-18 | Takeda Pharmaceutical Company Limited | Method for producing sulfonyl chloride compound |
| CN103951652B (en) * | 2014-04-18 | 2015-09-23 | 潍坊博创国际生物医药研究院 | 5-(2-fluorophenyl)-N-methyl isophthalic acid-(3-pyridyl sulfonyl)-1H-pyrroles-3-methylamine water soluble organic acid salt and injection and their preparation method |
-
2016
- 2016-03-29 MA MA041850A patent/MA41850A/en unknown
- 2016-03-30 US US15/563,417 patent/US20180085361A1/en not_active Abandoned
- 2016-03-30 KR KR1020177031036A patent/KR20170132260A/en unknown
- 2016-03-30 CR CR20170404A patent/CR20170404A/en unknown
- 2016-03-30 TN TNP/2017/000416A patent/TN2017000416A1/en unknown
- 2016-03-30 EP EP16718032.2A patent/EP3277279A1/en not_active Withdrawn
- 2016-03-30 EA EA201792148A patent/EA201792148A1/en unknown
- 2016-03-30 WO PCT/JP2016/061185 patent/WO2016159386A1/en active Application Filing
- 2016-03-30 JP JP2017550959A patent/JP2018513140A/en active Pending
- 2016-03-30 AU AU2016241069A patent/AU2016241069A1/en not_active Abandoned
- 2016-03-30 BR BR112017021024A patent/BR112017021024A2/en not_active Application Discontinuation
- 2016-03-30 MX MX2017012414A patent/MX2017012414A/en unknown
- 2016-03-30 PE PE2017001509A patent/PE20180195A1/en unknown
- 2016-03-30 SG SG11201706739WA patent/SG11201706739WA/en unknown
- 2016-03-30 CN CN201680020346.5A patent/CN107530335A/en active Pending
- 2016-03-30 CA CA2981244A patent/CA2981244A1/en not_active Abandoned
-
2017
- 2017-09-11 IL IL254419A patent/IL254419A0/en unknown
- 2017-09-14 CL CL2017002325A patent/CL2017002325A1/en unknown
- 2017-09-20 DO DO2017000218A patent/DOP2017000218A/en unknown
- 2017-09-25 PH PH12017501751A patent/PH12017501751A1/en unknown
- 2017-10-03 CO CONC2017/0010019A patent/CO2017010019A2/en unknown
- 2017-10-31 EC ECIEPI201772984A patent/ECSP17072984A/en unknown
-
2018
- 2018-11-01 US US16/178,335 patent/US20190070159A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2981244A1 (en) | 2016-10-06 |
| PH12017501751A1 (en) | 2018-04-11 |
| CR20170404A (en) | 2018-01-10 |
| CN107530335A (en) | 2018-01-02 |
| TN2017000416A1 (en) | 2019-01-16 |
| EP3277279A1 (en) | 2018-02-07 |
| MX2017012414A (en) | 2018-01-26 |
| PE20180195A1 (en) | 2018-01-26 |
| WO2016159386A1 (en) | 2016-10-06 |
| CO2017010019A2 (en) | 2018-02-20 |
| US20180085361A1 (en) | 2018-03-29 |
| US20190070159A1 (en) | 2019-03-07 |
| BR112017021024A2 (en) | 2018-07-03 |
| DOP2017000218A (en) | 2018-01-31 |
| MA41850A (en) | 2018-02-06 |
| CL2017002325A1 (en) | 2017-12-29 |
| IL254419A0 (en) | 2017-11-30 |
| EA201792148A1 (en) | 2018-02-28 |
| ECSP17072984A (en) | 2018-02-28 |
| AU2016241069A1 (en) | 2017-09-21 |
| JP2018513140A (en) | 2018-05-24 |
| KR20170132260A (en) | 2017-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258213A (en) | Pharmaceutical compounds | |
| GB201506658D0 (en) | Pharmaceutical compounds | |
| IL258246A (en) | Pharmaceutical compounds | |
| GB201504675D0 (en) | Pharmaceutical compounds | |
| GB201506660D0 (en) | Pharmaceutical compounds | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| GB201519352D0 (en) | Pharmaceutical compounds | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| ZA201900019B (en) | Pharmaceutical combinations | |
| GB201506933D0 (en) | Pharmaceutical compounds | |
| GB201502567D0 (en) | Pharmaceutical compounds | |
| GB201521462D0 (en) | Pharmaceutical composition | |
| IL254419A0 (en) | Novel pharmaceutical uses | |
| GB201515310D0 (en) | Pharmaceutical composition | |
| ZA201502073B (en) | Pharmaceutical composition | |
| GB201520862D0 (en) | Pharmaceutical composition | |
| ZA201508726B (en) | Pharmaceutical composition | |
| GB201506755D0 (en) | Novel pharmaceutical formulation | |
| SI3089740T1 (en) | Pharmaceutical composition | |
| GB201517133D0 (en) | New pharmaceutical use | |
| SG10201504332VA (en) | Pharmaceutical Composition | |
| GB201521015D0 (en) | Novel pharmaceutical uses | |
| GB201505526D0 (en) | Novel pharmaceutical uses | |
| GB201521456D0 (en) | Pharmaceutical composition |